Back to companies
Design Therapeutics, Inc.
DSGNUSNASDAQPharmaceuticals & HealthcareDesign Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$79.5mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API